1.0¶¶Òõ¶ÌÊÓƵFelix Dobbs/author/felix/Vincent Smith, PhD | ¶¶Òõ¶ÌÊÓƵrich600338<blockquote class="wp-embedded-content" data-secret="YHXkm7lb20"><a href="/profile/vincent-smith-phd/">Vincent Smith, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/profile/vincent-smith-phd/embed/#?secret=YHXkm7lb20" width="600" height="338" title="“Vincent Smith, PhD” — ¶¶Òõ¶ÌÊÓƵ" data-secret="YHXkm7lb20" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Vincent has spent the last 19 years creating DNA sequencing technologies that have transformed life science research and healthcare. Prior to joining the team at Broken String he was VP of Technology at Exact Sciences Innovation. He arrived at Exact via their 2020 acquisition of Base Genomics, an Oxford-based startup developing novel DNA methylation analysis...